Dr. KhadraGalaal

Dr. KhadraGalaal |Clyto Access

Consultant, MPH, FRCOG, UK


Expertise: Gynecological Surgery, Cervical Cancer, Ovarian Cancer, Cancer Diagnostic

Biography: Dr. Khadra Galaal qualifiedin medicine from Dundee University in 1992 and after specialty training in Obstetrics and Gynecology, with subspecialty training in Gynaecological Oncology at the Queen Elizabeth Hospital, Gates head. Later she moved to Royal Cornwall hospital in Truro where she was appointed as consultant gynaecological oncologist the lead of the gynaecological cancer services. In December 2015 she was appointed as the chair of the Peninsula NSSG. ,


Title: Intra-operative cell salvage use in ovarian cancer surgery



Intraoperative cell salvage (IOCS) involves the separation, centrifugation, washing and reinfusion into the patient’s blood. The use of IOCS reduces dependence on the limitedpool of banked blood, is immediately available in theatreand avoids the biological issues that occur with deterioration of stored blood products, such as oxidative damage. Several studies in oncology surgery have suggested that the use of conventional blood transfusion is associated with higher rates of cancer recurrence, increased postoperative infection and alloimmunisation compared to IOCS.  However, intraoperative cell salvage remains controversial in gynaecological cancer surgery, in part because of the theoretical risk of disseminating malignant tumour cells into a patient’s bloodstream. However, so far there are no studies substantiating poorer survival out comes in ovarian cancer with IOCS.


• To compare the overall survival and disease free survival for intraoperative cell salvage (IOCS) vs. allogeneic bloodtransfusion in women undergoing surgery for ovariancancer

 • To evaluate the rate of post-operative complicationsand length of hospital stay for intraoperative cell salvagevs. allogeneic blood transfusion in women undergoingsurgery for ovarian cancer


Related Conferences :

International Conference on Cancer Care and Cure